Clinical Trial Update: Emdogain and Straumann Bone Ceramic in Infrabony Defects [NA]

View source ↗

Summary

A terminated clinical trial evaluating Emdogain and Straumann Bone Ceramic for infrabony defects in periodontitis has posted results in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Emdogain (Enamel Matrix Derivative)
• Straumann Bone Ceramic (bone graft substitute (calcium phosphate ceramic))

Snippet

Sponsor: Institut Straumann AG | Conditions: Periodontitis | NA | Status: TERMINATED | Results posted: 2012-10-31